Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

Articles

GlaxoSmithKline has formed a joint venture with Indian vaccines company Biological E to research and develop a six-in-one combination pediatric vaccine to help protect children in India and other developing countries from certain infectious diseases.

GSK in Joint Venture for Pediatric Vaccine

FDA has approved Protein Sciences's FluBlok, a seasonal influenza vaccine made with novel technology. FluBlok uses recombinant DNA and a modified baculovirus (a virus that infects insects) to produce a safe and effective human flu vaccine. FDA approved Flublok for people 18–49 years old.

FDA Approves New Influenza Vaccine Manufactured with Novel Technology

Adopting a seven-step process resolves tableting problems.

Improving Tablet-Press Tooling Maintenance and Storage

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Micronization can be performed with a jet mill or bead mill.

Using Micronization to Reduce API Particle Size

The PATH Malaria Vaccine Initiative and Inovio Pharmaceuticals have announced a follow-on collaboration to advance the development of malaria vaccines and new vaccine delivery technologies.

Partnership Aims to Advance Malaria Vaccine R&D

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Janssen Pharmaceuticals, Inc. and GlycoVaxyn AG have entered into a three-year agreement to collaborate on the research and development of a multivalent bacterial vaccine utilizing GlycoVaxyn's bio-conjugation technology.

Janssen and GlycoVaxyn Collaborate on Vaccine Development

Simon Chalk is director of the BioPhorum Operations Group, simon@biophorum.com.

Is process-centered organization in biopharmaceutical manufacturing a stepping stone or a stumbling block?

The Transformation to Process-Centered Organization

PharmTech speaks to Ray O'Connor from the National Institute for Bioprocessing Research and Training (NIBRT) for an overview of aseptic processing.

Aseptic Processing: A Primer

Nathan Jessop is a columnist for Pharmaceutical Technology Europe.

Vaccine manufacturing was predicted in 2008 to be on the cusp of a golden era, but instead the industry has experienced cost pressures, high-profile liability cases and production setbacks.

Manufacturing Misery in Vaccines

Dr. Charles Kettler, director of Natoli Scientific, looks at the challenges that tablet scoring poses to tablet manufacturers.